Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Recs

0
Player Avatar sami2008 (< 20) Submitted: 7/3/2010 1:37:04 PM : Outperform Start Price: $6.79 PCYC Score: +355.60

its undervalue with big insider buy , my target 12 $

Report this Post 1 Comment
Member Avatar malibusunsetter (< 20) Submitted: 11/28/2011 3:41:08 PM
Recs: 0

Might want to update your target - perhaps $30 would be better.

Report this Post

Featured Broker Partners


Advertisement